BioCentury
ARTICLE | Company News

Bioventus sales and marketing update

August 15, 2016 7:00 AM UTC

Bioventus launched GELSYN-3 in the U.S. to treat pain associated with osteoarthritis of the knee. The wholesale acquisition cost (WAC) is $345 per 2 mL injection; one treatment comprises three injecti...